Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Amsden

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Antimicrobial Agents|September 28, 2001
Advanced-generation macrolides: tissue-directed antibioticsG W Amsden
International Journal of Antimicrobial Agents|April 16, 1999
Pharmacological considerations in the emergence of resistanceG W Amsden
The Annals of Pharmacotherapy|September 1, 1995
Macrolides versus azalides: a drug interaction updateG W Amsden
The Journal of Antimicrobial Chemotherapy|December 14, 2004
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?G W Amsden
The Journal of Antimicrobial Chemotherapy|August 25, 1999
Pneumococcal macrolide resistance--myth or reality?G W Amsden
Clinical Therapeutics|January 1, 1996
Erythromycin, clarithromycin, and azithromycin: are the differences real?G W Amsden
The Annals of Pharmacotherapy|April 17, 2001
Pneumococcal resistance: the treatment challengeG W Amsden, K Amankwa
Pharmacotherapy|July 1, 1996
Orthostatic hypotension induced by sertraline withdrawalG W Amsden, F Georgian
The Annals of Pharmacotherapy|October 1, 1992
Azithromycin: the first azalide antibioticC H Ballow, G W Amsden
Pharmacotherapy|April 22, 1999
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycinS A McConnell, G W Amsden
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Antimicrobial Agents|September 28, 2001
Advanced-generation macrolides: tissue-directed antibioticsG W Amsden
International Journal of Antimicrobial Agents|April 16, 1999
Pharmacological considerations in the emergence of resistanceG W Amsden
The Annals of Pharmacotherapy|September 1, 1995
Macrolides versus azalides: a drug interaction updateG W Amsden
The Journal of Antimicrobial Chemotherapy|December 14, 2004
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?G W Amsden
The Journal of Antimicrobial Chemotherapy|August 25, 1999
Pneumococcal macrolide resistance--myth or reality?G W Amsden
Clinical Therapeutics|January 1, 1996
Erythromycin, clarithromycin, and azithromycin: are the differences real?G W Amsden
The Annals of Pharmacotherapy|April 17, 2001
Pneumococcal resistance: the treatment challengeG W Amsden, K Amankwa
Pharmacotherapy|July 1, 1996
Orthostatic hypotension induced by sertraline withdrawalG W Amsden, F Georgian
The Annals of Pharmacotherapy|October 1, 1992
Azithromycin: the first azalide antibioticC H Ballow, G W Amsden
Pharmacotherapy|April 22, 1999
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycinS A McConnell, G W Amsden
Pageof 4